Showing 1 - 15 of 41 Next    

A Practical Guide to Pediatric Coronary Artery Imaging with Echocardiography

Brown, L. M., Duffy, C. E., Mitchell, C., Young, L.

J Am Soc Echocardiogr. Apr 2015; 28(4):379-391

Revision of the jones criteria for the diagnosis of acute rheumatic Fever in the era of Doppler echocardiography: a scientific statement from the american heart association

Gewitz, M. H., Baltimore, R. S., Tani, L. Y., Sable, C. A., Shulman, S. T., Carapetis, J., Remenyi, B., Taubert, K. A., Bolger, A. F., Beerman, L., Mayosi, B. M., Beaton, A., Pandian, N. G., Kaplan, E. L.

Circulation. May 19 2015; 131(20):1806-18

A Study of Cardiovascular miRNA Biomarkers for Kawasaki Disease

Rowley, A. H., Pink, A. J., Reindel, R., Innocentini, N., Baker, S. C., Shulman, S. T., Kim, K. Y.

Pediatr Infect Dis J. Dec 2014; 33(12):1296-9

Kawasaki disease: insights into pathogenesis and approaches to treatment

Shulman, S. T., Rowley, A. H.

Nat Rev Rheumatol. Aug 2015; 11(8):475-82

Kawasaki disease: a comprehensive review of treatment options

Patel, R. M., Shulman, S. T.

J Clin Pharm Ther. Dec 2015; 40(6):620-5

The Complexities of the Diagnosis and Management of Kawasaki Disease

Rowley, A. H.

Infect Dis Clin North Am. Sep 2015; 29(3):525-37

The transcriptional profile of coronary arteritis in Kawasaki disease

Rowley, A. H., Wylie, K. M., Kim, K. Y., Pink, A. J., Yang, A., Reindel, R., Baker, S. C., Shulman, S. T., Orenstein, J. M., Lingen, M. W., Weinstock, G. M., Wylie, T. N.

BMC Genomics. 2015/12/19; 16:1076

Kawasaki disease: part II. Complications and treatment

Bayers, S., Shulman, S. T., Paller, A. S.

J Am Acad Dermatol. Oct 2013; 69(4):513.e1-8; quiz 521-2

Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis

Bayers, S., Shulman, S. T., Paller, A. S.

J Am Acad Dermatol. Oct 2013; 69(4):501.e1-11; quiz 511-2

An evaluation of the validity of the animal models of kawasaki disease vasculopathy

Orenstein, J. M., Rowley, A. H.

Ultrastruct Pathol. Aug 2014; 38(4):245-7

CD84 is markedly up-regulated in Kawasaki disease arteriopathy

Reindel, R., Bischof, J., Kim, K. Y., Orenstein, J. M., Soares, M. B., Baker, S. C., Shulman, S. T., Perlman, E. J., Lingen, M. W., Pink, A. J., Trevenen, C., Rowley, A. H.

Clin Exp Immunol. Jul 2014; 177(1):203-11

Periostin is Upregulated in Coronary Arteriopathy in Kawasaki Disease and is a Potential Diagnostic Biomarker

Reindel, R., Kim, K. Y., Baker, S. C., Shulman, S. T., Perlman, E. J., Lingen, M. W., Trevenen, C., Rowley, A. H.

Pediatr Infect Dis J. Jun 2014; 33(6):659-61

Genetic and clinical determinants influencing warfarin dosing in children with heart disease

Nguyen, N., Anley, P., Yu, M. Y., Zhang, G., Thompson, A. A., Jennings, L. J.

Pediatr Cardiol. Apr 2013; 34(4):984-90

Integrins alpha4 and alphaM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy

Reindel, R., Baker, S. C., Kim, K. Y., Rowley, C. A., Shulman, S. T., Orenstein, J. M., Perlman, E. J., Lingen, M. W., Rowley, A. H.

Pediatr Res. Mar 2013; 73(3):332-6

Can a systems biology approach unlock the mysteries of Kawasaki disease?

Rowley, A. H.

Wiley Interdiscip Rev Syst Biol Med. Mar-Apr 2013; 5(2):221-9

Showing 1 - 15 of 41 Next